These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10977312)

  • 1. The search for smaller tumors. Breast-cancer studies could lead to better tests and earlier detection.
    Gorman C
    Time; 2000 Jun; 155(26):50. PubMed ID: 10977312
    [No Abstract]   [Full Text] [Related]  

  • 2. Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
    Lönneborg A; Aarøe J; Dumeaux V; Børresen-Dale AL
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1115-23. PubMed ID: 19671031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological tumor markers for monitoring breast cancer.
    Sölétormos G
    Dan Med Bull; 2001 Nov; 48(4):229-55. PubMed ID: 11767127
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast cancer screening and biomarkers.
    Brooks M
    Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection method and breast carcinoma histology.
    Newcomer LM; Newcomb PA; Trentham-Dietz A; Storer BE; Yasui Y; Daling JR; Potter JD
    Cancer; 2002 Aug; 95(3):470-7. PubMed ID: 12209738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
    Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full-field digital mammography compared with screen-film mammography in the detection of breast cancer: rays of light through DMIST or more fog?
    Tice JA; Feldman MD
    Breast Cancer Res Treat; 2008 Jan; 107(2):157-65. PubMed ID: 17377840
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tumor markers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2077-81. PubMed ID: 15570944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of mammographic screening at the Mammary Center of Debrecen in 1999 and 2000].
    Simon E; Péter M; Benkó K; Horkay E; Erdélyi G; Péter M; Szúcs-Farkas Z; Tóth J; Kovács I; Fülöp B
    Orv Hetil; 2002 Apr; 143(14):721-3. PubMed ID: 11975392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor associated glycoprotein (TAG) 12: a new tumor marker in breast cancer.
    Heinze T; Lichtenegger W
    Anticancer Res; 2000; 20(6D):5049-52. PubMed ID: 11326666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
    Zheng H; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography?
    Duffy SW; Tabar L; Vitak B; Warwick J
    Breast J; 2006; 12 Suppl 1():S91-5. PubMed ID: 16430402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis.
    Lu WL; Jansen L; Post WJ; Bonnema J; Van de Velde JC; De Bock GH
    Breast Cancer Res Treat; 2009 Apr; 114(3):403-12. PubMed ID: 18421576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
    Davis MA; Hanash S
    Breast Cancer Res; 2006; 8(6):217. PubMed ID: 17184556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When is breast magnetic resonance imaging recommended for cancer detection?
    Miller JC; Rafferty EA; Specht MC; Thrall JH; Lee SI
    J Am Coll Radiol; 2008 Mar; 5(3):224-6. PubMed ID: 18312973
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tumor markers in gynecological and breast cancer].
    Jobo T; Sato R; Kuramoto H
    Rinsho Byori; 2003 Dec; 51(12):1188-94. PubMed ID: 14743742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerized analysis of tissue density effect on missed cancer detection in digital mammography.
    Li L; Wu Z; Salem A; Chen Z; Chen L; George F; Kallergi M; Berman C
    Comput Med Imaging Graph; 2006 Jul; 30(5):291-7. PubMed ID: 16837164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells in breast cancer.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer.
    Wasif N; Garreau J; Terando A; Kirsch D; Mund DF; Giuliano AE
    Am Surg; 2009 Oct; 75(10):970-5. PubMed ID: 19886147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.